Piper Companies is currently seeking an Oncology Industry Liaison for a hybrid opportunity in Philadelphia, Pennsylvania (PA) to join a non-profit research group dedicated to saving cancer patients by facilitating access and promoting participation in oncology clinical trials.
Responsibilities of the Oncology Industry Liaison
- Coordinate activities related to the Pharmaceutical Industry, both internally and externally, by collaborating with various teams and partners, such as grants and contracts, clinical operations, protocol development, lab science, data management, and statistical teams, as well as study and committee chairs.
- Support business development efforts, including contract negotiation with Pharmaceutical Industry partners, providing approved scopes of work, budgets, and contract reviews to the contracts office.
- Monitor and manage contract deliverables for Pharmaceutical Industry partners, ensuring compliance with timelines and overseeing updates, accruals, drug requests, and protocol amendments through the designated portal.
- Facilitate the involvement of international entities on protocols, manage third-party drug distributors, vendors, and perform other assigned responsibilities.
Qualifications of the Oncology Industry Liaison
- 5+ years of experience in oncology clinical trials
- Management experience along with knowledge of clinical operations and business development activities
- Experience and knowledge of grants, budgeting, contracts, protocol development process, NCI, cooperative group trials, and working with pharmaceutical industry partners is required
- Bachelor’s Degree required; RN and / or RPh / PharmD preferred
Compensation for the Oncology Industry Liaison
- Salary Range : $140,000 - $150,000
- Benefits : Medical, Dental, Vision, 401k match, PTO, and tuition reimbursement
Keywords : industry liaison, oncology, cancer, clinical trials, cooperative group, non-profit, clinical research, medical research, pharma, pharmaceutical, development, study, management, manager, grants and contracts, budget, business development, protocol development process, NCI, national cancer institute, clinical operations, lab science, data management, statistics, committee, negotiation, deliverables, submissions, presentations, OUS, outside US, drug distributors, medical affairs, clin ops, liaison, liaise
LI-MK3
LI-HYBRID